We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Highly Elastic Protein Gel Encourages Wound Healing

By LabMedica International staff writers
Posted on 15 Jul 2015
A new study describes a protein-based gel that mimics many of the properties of elastic tissue—such as skin and blood vessels—when exposed to light.

Researchers at Brigham and Women's Hospital (Boston, MA, USA) and King Abdulaziz University (KAU; Jeddah, Saudi Arabia) successfully developed a photo-crosslinked elastin-like polypeptide (ELP) that contained only canonical amino acids and thiols from a pair of cysteine residues. More...
The thiols embedded into the ELP sequence caused formation of disulfide bonds when exposed to UV light. This allowed the researchers to create a highly elastic hydrogel with mechanical and swelling behavior properties that can be tuned by controlling ELP concentrations.

They then examined the biocompatibility of the engineered ELP hydrogels in vitro, as well as in vivo with subcutaneous implantation in rats. The ELP constructs demonstrated long-term structural stability in vivo and early and progressive host integration without immune response, suggesting their potential for supporting wound repair and as an in vivo hemostatic material for treating bleeding wounds. The researchers also found that combining the hydrogel with silica nanoparticles formed an even more powerful barrier. The study was published in the July 2015 issue of Advanced Functional Materials.

“Our hydrogel has many applications: it could be used as a scaffold to grow cells, or it can be incorporated with cells in a dish and then injected to stimulate tissue growth,” said co-senior author Nasim Annabi, PhD, of the Brigham biomedical engineering division. “In addition, the material can be used as a sealant, sticking to the tissue at the site of injury and creating a barrier over a wound. We see great potential for use in the clinic. Our method is simple, the material is biocompatible, and we hope to see it solve clinical problems in the future.”

“Hydrogels, jelly-like materials that can mimic the properties of human tissue, are widely used in biomedicine, but currently available materials have limitations,” added co-senior author Ali Khademhosseini, PhD, of Brigham and KAU.” Some synthetic gels degrade into toxic chemicals over time, and some natural gels are not strong enough to withstand the flow of arterial blood through them.”

Related Links:

Brigham and Women's Hospital
King Abdulaziz University



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.